Significant differences in red blood cell folate levels between best and worst responders to methotrexate in patients with rheumatoid arthritis.

被引：0
|
作者：
Kremer, JM
Davey, BT
Hall, MJ
Lawrence, DA
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Wadsworth Ctr Labs & Res, Albany, NY 12208 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
753
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] Homocysteine and folate status in methotrexate treated patients with rheumatoid arthritis.
    van Ede, AE
    Laan, RF
    Haagsma, CJ
    Blom, HJ
    Thomas, CJ
    de Bou, TM
    van de Putte, LB
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S342 - S342
  • [2] Contribution of methotrexate and folate polyglutamate levels to methotrexate effects during a dose escalation in rheumatoid arthritis.
    Kremer, Joel
    Greenstein, Neal
    Dervieux, Thierry
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S248 - S248
  • [3] Regulation of Folate Pathway Related Genes in Methotrexate naive and Methotrexate Treated Patients with Rheumatoid Arthritis.
    Blits, Marjolein
    Jansen, Gerrit
    Vosslamber, Saskia
    Assaraf, Yehuda G.
    Verweij, Cornelis L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S911 - S911
  • [4] Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: Relation to withdrawal and side effects
    Andersen, LS
    Hansen, EL
    Knudsen, JB
    Wester, JU
    Hansen, GVO
    Hansen, TM
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (05) : 830 - 837
  • [5] Methotrexate pharmacogenetics: Polymorphisms in gamma-glutamyl-hydrolase and reduced folate carrier predict intracellular methotrexate polyglutamates levels in patients with rheumatoid arthritis.
    Dervieux, T
    Kremer, J
    Lein, DO
    Capps, R
    Barham, R
    Meyer, G
    Do, J
    Smith, K
    Caldwell, J
    Furst, D
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S566 - S567
  • [6] Methotrexate inhibits TNFα and IFNγ in whole blood cultures of patients with rheumatoid arthritis.
    Gerards, AH
    de Groot, ER
    Dijkmans, BAC
    Aarden, LA
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S193 - S193
  • [7] Methotrexate polyglutamate concentrations in red blood cells correlates with disease activity and clinical response to methotrexate in rheumatoid arthritis.
    Dervieux, T
    Lein, DO
    Park, G
    Marcelletti, J
    Meyer, G
    Smith, K
    Walsh, M
    Kremer, J
    Furst, D
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S135 - S135
  • [8] B cell oligoclonality in the blood and joints of patients with rheumatoid arthritis.
    Itoh, K
    Patki, V
    Furie, R
    Chartash, E
    Jain, RI
    Gregersen, PK
    Chiorazzi, N
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1283 - 1283
  • [9] Differences between patients and physicians in willingness to accept risks in rheumatoid arthritis.
    Lenert, LA
    Sturley, A
    Elnitsky, C
    Athale, N
    Stallworth, T
    Kavanaugh, A
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S609 - S609
  • [10] Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis
    Smolenska, Z
    Kaznowska, Z
    Zarówny, D
    Simmonds, HA
    Smolenski, RT
    RHEUMATOLOGY, 1999, 38 (10) : 997 - 1002
12345